The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia
详细信息 查看全文
- 作者：Kerryn Butler ; M.Soc.Hlth.Counsela ; Kerryn.butler@unsw.edu.au" class="auth_mail" title="E-mail the corresponding author ; Carolyn Day ; Ph.D. ; B.Sc.b ; Paul Dietze ; Ph.D. ; B.Sc.c ; d ; Raimondo Bruno ; Ph.D. ; B.Sc.e ; Rosa Alati ; Ph.D. ; M.App.Sc.f ; Lucinda Burns ; Ph.D. ; M.P.H.a
- 关键词：HCV ; PWID ; OST ; Hepatitis C ; Injecting
- 刊名：Journal of Substance Abuse Treatment
- 出版年：2015
- 出版时间：November 2015
- 年：2015
- 卷：58
- 期：Complete
- 页码：90-94
- 全文大小：215 K
文摘
- •
Prior anti-HCV testing was reported by a high proportion of a typical sample of PWID.
- •
Lower levels of PCR testing suggest current testing policies may be inadequate.
- •
Delivery of HCV through OST potentially excludes two-thirds of a typical PWID sample.
- •
Other settings in addition to OST should be considered to ensure good coverage.